Patents by Inventor Katherine Call

Katherine Call has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transposon mediated multiplex sequencing
    Patent number: 7229798
    Abstract: The present invention relates to an automated method of transposon-mediated multiplex sequencing of DNA fragments inserted into a vector. It relates more particularity to an increased efficiency in such automated methods, where the increased efficiency is obtained by screening out before the sequencing those constructs in which the transposon inserted into the vector sequence. This prevents a waste of time and resources in performing reactions sequencing the vector instead of the DNA fragments of interest.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: June 12, 2007
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Paul R. August, Pamela J. Keagle, Henry Long, Anna Wiencis Montmayeur, Katherine Call, Michael Draper
  • Genes involved in osteogenesis, and methods of use
    Publication number: 20060030541
    Abstract: The present invention relates to methods of diagnosis, therapy, and screening of new therapeutic compounds in the field of osteogenesis, based on the differential expression observed for the genes of the invention, represented by SEQ ID No 2, 7, 22, 25, 33, 35, 37, 38, 42, 47, 64, 69 or 77, 82, 97, 100, 108, 110, 112, 113, 117, 122, 139, 151, 158, 160, 172, 182, 184, 187, 188, 194.
    Type: Application
    Filed: October 7, 2005
    Publication date: February 9, 2006
    Applicant: Proskelia
    Inventors: Teresa Garcia, Sergio Roman Roman, Roland Baron, Katherine Call, Joachim Theilhaber, Timothy Connolly, Amanda Jackson, Steven Bushnell, Georges Rawadi
  • Genes involved in osteogenesis, and methods of use
    Publication number: 20040265808
    Abstract: The present invention relates to methods of diagnosis, therapy, and screening of new therapeutic compounds in the field of osteogenesis, based on the differential expression observed for the genes of the invention, represented by SEQ ID No 1 to SEQ ID No 150, or SEQ ID No 151, 152 or 153, or SEQ ID No 154 to SEQ ID No 196, or SEQ ID No 197 to SEQ ID No 210, or SEQ ID No 211 to SEQ ID No 229, or SEQ ID No 230 to SEQ ID No 234, or SEQ ID No 235 to SEQ ID No 245.
    Type: Application
    Filed: May 3, 2004
    Publication date: December 30, 2004
    Inventors: Teresa Garcia, Sergio Roman Roman, Roland Baron, Katherine Call, Joachim Theilhaber, Timothy Connolly, Amanda Jackson, Steven E Bushnell, Georges Rawadi
  • Transposon mediated multiplex sequencing
    Publication number: 20030219779
    Abstract: The present invention relates to an automated method of transposon-mediated multiplex sequencing of DNA fragments inserted into a vector. It relates more particularity to an increased efficiency in such automated methods, where the increased efficiency is obtained by screening out before the sequencing those constructs in which the transposon inserted into the vector sequence. This prevents a waste of time and resources in performing reactions sequencing the vector instead of the DNA fragments of interest.
    Type: Application
    Filed: May 5, 2003
    Publication date: November 27, 2003
    Inventors: Paul R. August, Pamela J. Keagle, Henry Long, Anna Wiencis Montmayeur, Katherine Call, Michael Draper